Business · 17/12/1998

FDA Proposes Revision to Meetings and Correspondence Regulations

The Food and Drug Administration (FDA) is proposing to update its rules regarding meetings, correspondence, and public calendars to improve clarity and efficiency, and to redirect resources to more pressing public health concerns, as part of the President's Regulatory Reinvention Initiative.